products

Apixaban CAS 503612-47-3 C25H25N5O4 Pharmaceutical Grade Chemicals

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Circulatory System Drugs API - 18
Minimum Order Quantity: 1KG
Price: Negotiation
Packaging Details: Aluminum foil bag , kraft paper bag
Delivery Time: Within 7 days
Payment Terms: L/C, T/T
Supply Ability: Can be customized according to customer requirements
Detail Information
Name: Apixaban CAS: 503612-47-3
Form: Powder Molecular Formula: C25H25N5O4
Molecular Weight: 459.504 Density: 1.42g/cm3
High Light:

pharmaceutical raw materials

,

raw material for medicine manufacturing


Product Description

Apixaban CAS 503612-47-3 C25H25N5O4 Pharmaceutical Grade Chemicals
 

Description:

 

In 2007, bristol-myers squibb and Pfizer formally implemented the global strategic cooperation agreement, jointly developing and selling the anticoagulant product apixaban;In 2011, it was the first to approve the prevention of venous thrombosis in adult patients undergoing elective hip or knee replacement surgery in the 27 eu countries, Iceland and Norway.In January 2013, it obtained the import drug license issued by the state food and drug administration of China to prevent venous thromboembolism (VTE) in adult patients with selective hip or knee replacement, and then it was officially released in China in April 2013.

Apixaban is a novel oral anticoagulant, a novel oral factor Xa inhibitor, which is used to prevent and treat thrombosis.

The recommended dose is 2.5mg, taken orally twice a day, which is effective in preventing venous thromboembolism without increasing the risk of bleeding, and does not require routine monitoring of coagulation function or dose adjustment.

 

Specifications:
 

Description

White powder

Complies

Identification

IR

Complies

 

HPLC

Complies

Heavy metal

≤10ppm

5ppm

Pb

≤3ppm

1.5ppm

Hg

≤0.1ppm

0.05ppm

Cd

≤1ppm

0.2ppm

Loss on drying

≤0.5%

0.12

Residue on lgnition

≤0.1%

0.03

Single impurity

≤0.5%

0.12

Total impurity

≤1.0%

0.29

Total bacteria

≤1000cfu/g

<1000

Yeast and Mould

≤100 cfu/g

<000

E.coli/25g

Absent

Absent

Salmonella/25g

Absent

Absent

Assay

≥99.0%

99.4%

Conclusion

Conforms with USP/EP standards

 

Application: 
 

The drug is used to prevent venous thromboembolism (vte) events in adult patients undergoing elective hip or knee replacement.


Our strengths:
 
We can customize according to customer's requirement.
If you have any question pls mail us or call us.
 

 
 

Contact Details
Fedor

Phone Number : +86 18989305995

WhatsApp : +18989305995